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Introduction
NFBD1 (nuclear factor with BRCT domains protein 1)/MDC1 (mediator of DNA damage checkpoint protein 1) (henceforth NFBD1) has been initially identified by a random screening of a cDNA library derived from a human immature myeloid cell line, KG-1 (1) . According to their results, NFBD1 was mapped at human chromosome 6p21 and encodes a novel protein of 2089 amino acid residues, which sheared no significant structural similarity to known proteins filed in the data bases. Koonin et al. found that NFBD1 contains a conserved repeated motif termed BRCT (BRCA1 C-terminus) domain at its COOH terminus (2) . The BRCT domain was initially detected in the 202 amino acid residues COOH-terminal globular domain of breast cancer suppressor BRCA1, and the structurally related motif was also found at the COOH-terminal region of tumor suppressor p53-binding protein 53BP1 and cell cycle checkpoint protein RAD9. Therefore, NFBD1 is a member of BRCT superfamily including BRCA1. Previously, we have found for the first time that NFBD1 is a nuclear DNA-binding protein and also has an anti-apoptotic function as examined by in vitro DNA-binding assay and colony formation assay, respectively (3) .
The cellular genome is continuously exposed to the endogenous DNA damage which occurs during normal DNA replication as well as the exogenous DNA damage insults caused by a variety of genotoxic agents such as ionizing radiation [4] [5] [6] . To maintain the genomic integrity is particularly important for cell survival. Without proper DNA damage response, DNA damage often results in the induction of genomic instability, which contributes to the development malignancies (7, 8) . To avoid DNA damage-mediated genomic alterations and also transfer damaged DNA to daughter cells, cells have developed the complicated signaling pathway which delays or arrests cell cycle progression and coordinates DNA repair in response to DNA damage (9, 10) . When DNA damage is highly toxic, cells with unrepaired or incorrectly repaired genome DNA undergo apoptotic cell death. This DNA damage response pathway is a highly conserved cellular process throughout evolution (11) . Alternatively, when cells fail to repair damaged DNA correctly due to the premature termination of DNA replication forks as well as DNA double-strand breaks, cells undergo cellular senescence to protect them from initiation and/or progression of cancer (12) .
Although p53-dependent induction of CDK inhibitor p21 WAF1 contributes to the promotion of cell cycle arrest and/or cellular senescence and NFBD1 inhibits pro-apoptotic activity of p53 (13, 14) , it has remained unclear how cells choose their cell fate in response to DNA damage.
The initial event in response to DNA damage is the activation of sensor kinases of the phosphatidylinositol 3-linase-like protein kinase (PIKK) family including ATM (ataxia telangiectasia mutated), ATR (ataxia telangiectasia mutated and Rad3-related) and DNAPK (DNA-dependent protein kinase) (15) (16) (17) . These protein kinases which are activated by a variety of DNA damage such as ionizing radiation, UV exposure, anti-cancer drug treatment and replication stress, phosphorylate multiple substrate proteins, and thereby leading to a proper DNA damage response. Considering that ATM plays a pivotal role in DNA damage response, loss of function mutations of ATM and/or genes involved in the regulation of ATM catalytic activity cause severe genetic disorders manifested by genomic instability, radiation sensitivity and cancer predisposition (18) . Upon DNA damage, the histone variant H2AX at the sites of DNA damage is phosphorylated at Ser-139 ( ) by the above-mentioned sensor kinases to form nuclear foci (16, 19, 20) . Cells prepared from H2AX-deficient mice exhibit radiation-induced genomic aberrations, suggesting that H2AX is tightly involved in proper DNA damage response (21, 22 also participates in the regulation of DNA damage response (26) .
In addition to the regulation of DNA damage response, NFBD1 is closely involved in the regulation of cell cycle progression. It has been well-established that a multi-protein complex termed APC/C (anaphase promoting complex/cyclosome) with an E3 ubiquitin protein ligase activity is a major regulator of the cell cycle progression. APC/C is required to induce progression and exit from mitosis by stimulating the proteolytic degradation of its substrates such as mitotic seculin and cyclin B (27) (28) (29) . The activity of APC/C is regulated during mitosis by two independent activators, Cdc20 and Cdh1. Recently, it has been shown that NFBD1 binds to and activates APC/C through the interaction with Cdc20 (30) . Indeed, we have demonstrated that knocking down of NFBD1 results in the induction of G2 arrest (31) . In the present review article, we describe the functional importance of NFBD1 in the regulation of DNA damage response, cell cycle progression and carcinogenesis.
Structure of NFBD1
NFBD1 is a large nuclear adaptor protein (2089 amino acid residues) with an 7
These modular domains (FHA and BRCT domains) are often found in cellular proteins implicated in DNA damage response and/or cell cycle control (32, 33) .
On the other hand, PST domain has no significant homology to any other cellular proteins (25) . FHA domain has been considered to be a phospho-protein binding module commonly found in signaling proteins (34) (35) (36) (37) (46) . In contrast to BRCA1, the BRCT domains of NFBD1 did not have the transcriptional potential (3). Therefore, the transactivation potential might not be a common functional feature of the BRCT domain.
Initiation of DNA damage response
The early molecular event which occurs in response to DNA damage, is a DNA damage-induced auto-phosphorylation of ATM at Ser-1981 (16 (57) .
Interaction between NFBD1 and p53
Since knocking down of NFBD1 led to an increase in a sensitivity to ionizing radiation and anti-cancer drug camptothecin, NFBD1 was required for cell survival in response to DNA damage (49) . In support with this notion, Yang et al.
described that depletion of NFBD1 sensitizes human esophageal cancer cells to chemotherapeutic drugs such as adriamycin (ADR) and cisplatin (CDDP) (58 in response to DNA damage. According to our previous observations, expression level of NFBD1 was sharply decreased in A549 cells exposed to ADR as examined by RT-PCR and immunoblotting (14). Therefore, DNA damage-mediated down-regulation of NFBD1 was regulated at least in part at transcriptional level. We have also found that the general transcription factor Sp1 acts as a transcriptional activator for NFBD1 (60) .
Termination of DNA damage response
As mentioned above, NFBD1 together with  plays an essential role in 
Regulatory role in the mitotic progression
Progression through mitosis is regulated by the sequential proteolytic degradation of mitotic proteins such as Plk1, cyclin B and securin, which is mediated by ubiquitin/proteasome pathway. It has been well-established that a large protein complex termed APC/C containing the intrinsic E3 ubiquitin protein ligase activity, controls the ubiquitin-dependent proteolytic degradation of the above-mentioned mitotic proteins, and is essential for proper cell cycle progression (27) (28) (29) . APC/C is composed of at least 12 subunits and is active from early mitosis through late G1 phase of the cell cycle (66, 67) . At the end of G1 phase, APC/C becomes inactive to allow the accumulation of essential cell cycle regulators in cells (29) . Previous studies suggest that APC/C-mediated degradation of substrate proteins (cyclin B1, Plk-1 and phosphorylated histone H3 at Ser-10) requires CBP, which acts as an E4 ubiquitin protein ligase (68) . E4 ubiquitin ligase catalyzes the elongation of polyubiquitinated chain to allow the targeting of the polyubiquitinated sustrate proteins for degradation by proteasome (69) . Catalytic activity and substrate specificity of APC/C are regulated during mitosis by one of two closely related activator proteins such as Cdc20 and Cdh1 (70, 71) . It has been shown that Cdc20 and Cdh1 recognize the destruction box (D box), and Cdh1 also recognizes the KEN box (72) (73) (74) . On the other hand, a F-box protein termed Emi1 acts as an inhibitor for APC/C (75).
Emi1 inhibits APC/C by direct binding to Cdc20 and Cdh1 and thereby blocking the interaction between APC/C and its substrates.
Uncontrolled proteolysis of the cell cycle regulators which might be due to the dysfunction of APC/C, is tightly involved in the induction of genomic instability and subsequent carcinogenesis. For example, inhibition of APC/C-mediated proteolytic degradation of securin or cyclin B resulted in genomic instability (76, 77) . When Emi1 escapes from the proteolytic degradation, abnormal accumulation of substrates of APC/C takes place and cells undergo mitotic catastrophe (78, 79) . Indeed, various cancers overexpress Emi1 (80) . In addition, securin is frequently overexpressed in hematopoietic neoplasms, and the high expression levels of cyclin B are detectable in colon and lung cancers (81) (82) (83) (84) (85) .
These observations suggest that the proper mitotic checkpoint activation pathway is disrupted in certain cancers. that, in addition to Cdc27, NFBD1 binds directly to Cdc20 as well as CBP and regulates catalytic activity of APC/C (86) . Based on their results, NFBD1 acts as a molecular bridge between Cdc20 and APC/C and thereby promoting efficient APC/C activation during mitotic progression. In support with this notion, knocking down of the endogenous NFBD1 resulted in a mitotic arrest, which might be due to the decreased recruitment of Cdc20 to APC/C mediated by NFBD1 ( Fig. 4) .
Recently, we have found that Plk1 interacts with NFBD1 and phosphorylates its PST domain (87) . Based on our observations, Plk1-mediated phosphorylation of NFBD1 was required for M phase entry. Taken together, in addition to DNA damage signaling pathway, NFBD1 is involved in the regulation of mitotic progression.
Functional implications in carcinogenesis
Since the constitutive activation of DNA damage response pathway has been shown to take place in the early precursor lesions of several types of human cancers (88), it is highly likely that the activated DNA damage checkpoints triggered at least in part by NFBD1 provide an early biological barrier against the genomic instability and the subsequent progression of cancers. Consistent with this notion, NFBD1-deficient mice exhibited growth retardation, male infertility, immune defects, chromosome instability, DNA repair defects and radiation sensitivity (26) . In a good agreement with these observations, Bartkova et al.
described that NFBD1 is aberrantly down-regulated in subsets of lung and breast cancers (89) . In contrast, Yuan et al. described that NFBD1 is expressed higher in human cervical cancer tissues than in matched normal ones, and knockdown of NFBD1 inhibits tumor growth in nude mice, suggesting that NFBD1 has an oncogenic potential (90) . In accordance with these observations, Indeed, inactivation of NFBD1 has been found in a large number of human breast and lung cancers, which might have a significant impact on carcinogenesis (88, 93) .
Conclusions
Upon DNA damage, NFBD1 acts as an adaptor protein to recruit DNA repair machinery to the sites of DNA damage marked by  . NFBD1 also contributes to the proper mitotic progression through the regulation of the activity 20 of APC/C complex. Since NFBD1-deficient mice displayed the remarkable DNA repair defect and genomic instability, dysfunction of NFBD1 might accumulate cells with serious DNA damages and thereby leading to the genesis and/or development of cancers. Thus, it is quite important to check the genomic status and expression level of NFBD1 might contribute to the early detection of precancers and/or cancers.
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